These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26444353)
61. [Laboratory and morphologic parameters in patients with lupus nephritis]. Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312 [TBL] [Abstract][Full Text] [Related]
62. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing. Khubchandani SR; Bichle LS Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895 [TBL] [Abstract][Full Text] [Related]
63. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764 [TBL] [Abstract][Full Text] [Related]
64. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis. Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776 [TBL] [Abstract][Full Text] [Related]
65. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort. Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214 [TBL] [Abstract][Full Text] [Related]
66. Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years. Bhandari B; Pal A; Maulik S; Chakraborti S J Indian Med Assoc; 2012 Oct; 110(10):710-4. PubMed ID: 23738404 [TBL] [Abstract][Full Text] [Related]
68. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus. Kawazoe M; Kaneko K; Yamada Z; Masuoka S; Mizutani S; Yamada S; Shikano K; Sato H; Kaburaki M; Muraoka S; Kawai S; Nanki T Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862 [TBL] [Abstract][Full Text] [Related]
69. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Bogdanović R; Nikolić V; Pasić S; Dimitrijević J; Lipkovska-Marković J; Erić-Marinković J; Ognjanović M; Minić A; Stajić N Pediatr Nephrol; 2004 Jan; 19(1):36-44. PubMed ID: 14634858 [TBL] [Abstract][Full Text] [Related]
70. Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis. Zhang J; Zhao Z; Hu X Cell Biochem Biophys; 2015 May; 72(1):197-201. PubMed ID: 25490907 [TBL] [Abstract][Full Text] [Related]
71. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775 [TBL] [Abstract][Full Text] [Related]
72. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort. Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277 [TBL] [Abstract][Full Text] [Related]
73. Transition of morphologic features in lupus nephritis: does steroid therapy accelerate glomerulosclerosis? Makino H; Yamasaki Y; Shikata K; Kashihara N; Sugiyama H; Ogura T; Ota Z Intern Med; 1995 Oct; 34(10):982-7. PubMed ID: 8563100 [TBL] [Abstract][Full Text] [Related]
74. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458 [TBL] [Abstract][Full Text] [Related]
75. Clinicopathological correlations of paediatric lupus nephritis. Marks SD; Sebire NJ; Pilkington C; Tullus K Pediatr Nephrol; 2007 Jan; 22(1):77-83. PubMed ID: 17106692 [TBL] [Abstract][Full Text] [Related]
76. Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study. Kostik M; Kalashnikova E; Rinat R; Isupova E; Gaidar E; Soloviev AA; Masalova V; Snegireva L; Kornishina T; Abramova N; Suspitsin E; Sorokina L; Kaneva M; Dubko MF; Lubimova N; Kuchuinskaya E; Kalashnikova O; Chasnyk V Biomedicines; 2023 May; 11(5):. PubMed ID: 37239173 [TBL] [Abstract][Full Text] [Related]
77. Protective role of anti-ribosomal P antibody in patients with lupus nephritis. Kang JH; Park DJ; Choi SE; Yim YR; Kim JE; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee JK; Lee SS Int J Rheum Dis; 2019 May; 22(5):913-920. PubMed ID: 30809965 [TBL] [Abstract][Full Text] [Related]
78. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477 [TBL] [Abstract][Full Text] [Related]
79. Outcome of lupus nephritis in Iranian children: prognostic significance of certain features. Ataei N; Haydarpour M; Madani A; Esfahani ST; Hajizadeh N; Moradinejad MH; Gholmohammadi T; Arbabi S; Haddadi M Pediatr Nephrol; 2008 May; 23(5):749-55. PubMed ID: 18270752 [TBL] [Abstract][Full Text] [Related]
80. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus. Badr AMM; Farag Y; Abdelshafy M; Riad NM Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]